Business Wire

Reproductions of Rare Vatican Manuscript to Be Presented to Project Donors

Del

The Vatican Apostolic Library, Digita Vaticana, NTT DATA Corporation and Canon Inc. today announced their agreement to present special faithful reproductions of a rare 1,600-year-old manuscript to the first 200 people/organizations who donate 500 euros or more to support an ongoing project that is using NTT DATA technology to digitally archive thousands of manuscripts at the Vatican Library. The reproductions will give the beholders the impression of looking at the original masterpiece. Donations should be made to Digita Vaticana (www.digitavaticana.org), a nonprofit organization that raises funds for the Library’s digitization project. Beginning today, reproductions, certified by the Library, can be booked by making a donation, and Digita Vaticana will distribute this special gift to donors and supporters of the project in September.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160708005153/en/

Vergilius Vaticanus, Folio XXIIr, Creusa trying to detain Aeneas from the battle, 4th cent.

Vergilius Vaticanus, Folio XXIIr, Creusa trying to detain Aeneas from the battle, 4th cent.

The facsimile will accurately reproduce the appearance of the manuscript. The digitization process is being handled by NTT DATA. Faithful reproduction of the original manuscript is made possible through the combination of Canon’s proprietary material appearance image-processing technology and Canon Group company Océ’s elevated printing technology.

The collaboration demonstrates how advanced technologies can be used to preserve and share ancient treasures as evidence of humankind’s universal cultural heritage. Canon’s innovative image-processing and printing technologies will produce exceptionally faithful reproductions of Folio 22 recto of the Vatican Virgil, one of the most important pages in the Vatican Library’s collections. A limited edition of 200 copies of the reproduction will be distributed to donors and supporters of the project.

The Vatican Virgil, a manuscript created in ancient Rome around 400 A.D., contains fragments of Virgil’s Aeneid and Georgics. Originally, it very likely included all of the canonical works of the Latin poet. One of the oldest manuscripts in existence today, it still contains the text of the Aeneid, with 76 surviving leaves and 50 illustrations. The Folio 22 recto includes an illustration from the Aeneid that depicts Creusa trying to detain her husband Aeneas from battle.

NTT DATA joined the Vatican Apostolic Library’s digital archiving project in April 2014. The project aims to create digital copies of some 3,000 ancient manuscripts for archiving and sharing with both scholars and the general public around the world.

“We are honored to use our state-of-the-art technology to help the Vatican Apostolic Library preserve these irreplaceable cultural treasures as a legacy for future generations,” said Toshio Iwamoto, President and CEO of NTT DATA. “NTT DATA will continue to leverage its digital expertise in support of the arts and academia for the benefit of future generations.”

“Our library is an important storehouse of the global culture of humankind,” said Monsignor Cesare Pasini, Prefect of the Vatican Apostolic Library. “We are delighted the process of digital archiving will make these wonderful ancient manuscripts more widely available to the world and thereby strengthen the deep spirit of humankind’s shared universal heritage.”

“Every donation will be used to support our mission of preserving the priceless historical manuscripts of the Vatican Apostolic Library,” said Maite Bulgari, President of Digita Vaticana. “The reproduction that will be sent to 200 donors will enable people to understand how digitization and new technologies can reproduce the actual appearance and the essence of a page from an ancient manuscript created some 1,600 years ago.”

“We are honored that Canon’s cutting-edge technology is being used to create the reproductions of this culturally important document,” said Fujio Mitarai, Chairman and CEO of Canon Inc. “The process used to create these visually and texturally accurate reproductions of the 1,600-year-old Vatican manuscript employs our material appearance image-processing technology to facilitate the digitization of such material appearance information as color data, subtle surface contours, and gloss. This information is then optimally controlled to replicate the material appearance properties of the original document. Through our technology, Canon will continue contributing to the development of culture and the arts.”

The Vatican Apostolic Library and NTT DATA expect to complete their manuscript-digitization project by March 2018. Individuals and organizations interested in supporting the project are invited to visit Digita Vaticana at www.digitavaticana.org.

About the Digital Archiving Project of the Vatican Apostolic Library

In April 2014, the Vatican Apostolic Library and NTT DATA began working on the project of digitally archiving manuscripts of the Library, with plans to digitize approximately 3,000 handwritten manuscripts by 2018. The Library’s overall project is intended to digitally archive all manuscripts preserved in the Library, amounting to some 82,000 manuscripts and 41 million pages. High-definition images are observable at the Library’s website, DigiVatLib (http://digi.vatlib.it), using a special viewer built with NTT DATA’s digital archive solution technology, AMLAD™. On May 17, 2016, the website was renewed to provide access to the Library’s full archive of digitized manuscripts and incunabula. DigiVatLib complies with the International Image Interoperability Framework (IIIF), an open standard for easy access by researchers worldwide.

About the Vatican Apostolic Library

The Vatican Apostolic Library, also known as the “Popes’ Library,” is located in Vatican City. It was founded by Pope Nicholas V Parentucelli (1447-1455) in the Palace of Popes. In the late 16th century it was moved to the Sistine Hall by Pope Sixtus V Peretti (1585-1590), on the top floor of a new building built to delimit northward the Belvedere Court. The current seat, which began with Pope Leo XIII Pecci (1878-1903), includes adjacent buildings into which the Library was expanded to accommodate additional acquisitions and donations during its long history. The Library documents the history and thinking of humankind through arts and literature, mathematics and science, and law and medicine, from the early Christian era to the present day. It encompasses works of numerous languages and cultures ranging from the Far East to pre-Columbian America. The collection encompasses 82,000 manuscripts, 100,000 archival units, 1.6 million printed books (including 8,700 incunabula printed before 1501), 400,000 coins and medals, 100,000 prints, drawings and matrices, and 150,000 photographs.

About Digita Vaticana

Digita Vaticana Onlus is a non-profit organization founded in 2014 to promote the conversion of 82,000 Vatican Library’s manuscripts into digital format. It conducts fundraising activities to support this digitization initiative, and it is developing communication channels to disseminate and articulate the immeasurable value of these irreplaceable historical documents. For details, and to book a limited-edition copy of the reproduction, visit www.digitavaticana.org.

About NTT DATA

NTT DATA (TOKYO:9613) is a leading IT services provider and global innovation partner headquartered in Tokyo, with business operations in over 40 countries. Its emphasis is on long-term commitments, combining global reach with local intimacy to provide premier professional services varying from consulting and systems development to outsourcing. The company has been participating in the Vatican Apostolic Library’s project to digitally archive irreplaceable manuscripts since March 20, 2014. For more information, visit www.nttdata.com.

About Canon Inc.

Canon Inc. (NYSE:CAJ)(TOKYO:7751), headquartered in Tokyo, Japan, is a leader in the fields of professional and consumer imaging equipment, information systems and industrial equipment. Canon’s cooperation with the Vatican Apostolic Library digitization project is an initiative that is in keeping with the company’s corporate philosophy of kyosei. In accordance with this philosophy, Canon carries out a wide range of social contribution activities with the aim of contributing to a world in which all people live and work harmoniously together. Visit the Canon Inc. global website at global.canon.

Notes

AMLAD™ is a domestic trademark of the NTT DATA Corporation.
All other products, corporations and organization names are registered trademarks or corporate trademarks.

Contact information

Media inquiries
NTT DATA Corporation
Weber Shandwick
(Ms.) Ayumi Matsubara
nttdata@webershandwick.com
+81-90-9006-5841 (phone)
or
Canon Inc.
Richard S. Berger
PR Division
richard.berger@canon.co.jp
+81-3-5482-8055 (phone)
+81-3-5482-5130 (fax)

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i